Results 121 to 130 of about 3,500 (185)

Filgotinib in Moderate-to-Severe Crohn's Disease: A Network Meta-Analysis of Efficacy and Adverse Events. [PDF]

open access: yesHealthcare (Basel)
Khoshaim YA   +11 more
europepmc   +1 more source

Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry. [PDF]

open access: yesRMD Open
Sonomoto K   +9 more
europepmc   +1 more source

Emerging role of Janus kinase inhibitors in ulcerative colitis management. [PDF]

open access: yesWorld J Gastrointest Pharmacol Ther
Ahsan MU   +5 more
europepmc   +1 more source

Comparative Efficacy of Janus Kinase Inhibitors (JAKis) for Ulcerative Colitis in Japanese Regional Healthcare Facilities: A Real-World Database Study. [PDF]

open access: yesCureus
Itoi Y   +16 more
europepmc   +1 more source

Kinetics of intestinal ultrasound and shear-wave elastography to assess early response in ulcerative colitis patients treated with filgotinib. [PDF]

open access: yesJ Crohns Colitis
Pruijt MJ   +7 more
europepmc   +1 more source

PO:07:096 | Safety of filgotinib in the treatment of rheumatoid arthritis: results from the multicentre SOFIA study

open access: yesReumatismo
Background. To evaluate safety of filgotinib in terms of frequency, severity, and type of adverse events (AEs) and to identify predictors of AEs in a multicentre cohort of patients with rheumatoid arthritis (RA).   Materials and Methods.
Società Italiana di Reumatologia
doaj  

Home - About - Disclaimer - Privacy